Design, Synthesis, and Crystal Structure of Hydroxyethyl Secondary Amine-Based Peptidomimetic Inhibitors of Human β-Secretase
Michel Maillard(CHDI Foundation), Varghese John(University of California, Los Angeles), Michael S. Dappen(Pfizer (United States)), Eugene D. Thorsett, Shumeye Mamo(Pfizer (United States)), Thomas L. Emmons(Pfizer (United States)), Roy K. Hom(Pfizer (United States)), Timothy E. Benson(Pfizer (United States)), Alfredo G. Tomasselli(Pfizer (United States)), Nancy Jewett(Sunesis (United States)), Joseph B. Moon(Pfizer (United States)), John A. Tucker(Pfizer (United States)), Michael J. Bienkowski(Pfizer (United States)), D. Bryan Prince(Pfizer (United States)), Sukanto Sinha(Sunesis (United States)), Louis Brogley(Pfizer (United States)), Donna J. Paddock(Pfizer (United States)), Danielle D. Woods(Pfizer (United States))
Cited by 111
Related Papers
Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain
|Journal of Neurochemistry|2001|879
Structural basis of substrate discrimination and integrin binding by autotaxin
|Nature Structural & Molecular Biology|2011|280
Ayurvedic medicinal plants for Alzheimer's disease: a review
|Alzheimer s Research & Therapy|2012|212
Human β-Secretase (BACE) and BACE Inhibitors
|Journal of Medicinal Chemistry|2003|146